255 related articles for article (PubMed ID: 21118743)
1. Pharmacokinetics of armodafinil and modafinil after single and multiple doses in patients with excessive sleepiness associated with treated obstructive sleep apnea: a randomized, open-label, crossover study.
Darwish M; Kirby M; D'Andrea DM; Yang R; Hellriegel ET; Robertson P
Clin Ther; 2010 Nov; 32(12):2074-87. PubMed ID: 21118743
[TBL] [Abstract][Full Text] [Related]
2. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
Krystal AD; Harsh JR; Yang R; Rippon GA; Lankford DA
J Clin Psychiatry; 2010 Jan; 71(1):32-40. PubMed ID: 20051221
[TBL] [Abstract][Full Text] [Related]
4. Optimal treatment of obstructive sleep apnea and excessive sleepiness.
Rosenberg R; Doghramji P
Adv Ther; 2009 Mar; 26(3):295-312. PubMed ID: 19337706
[TBL] [Abstract][Full Text] [Related]
5. Armodafinil in the treatment of excessive sleepiness.
Bogan RK
Expert Opin Pharmacother; 2010 Apr; 11(6):993-1002. PubMed ID: 20307223
[TBL] [Abstract][Full Text] [Related]
6. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.
Hirshkowitz M; Black JE; Wesnes K; Niebler G; Arora S; Roth T
Respir Med; 2007 Mar; 101(3):616-27. PubMed ID: 16908126
[TBL] [Abstract][Full Text] [Related]
7. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628
[TBL] [Abstract][Full Text] [Related]
8. Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.
Roth T; Rippon GA; Arora S
Sleep Breath; 2008 Mar; 12(1):53-62. PubMed ID: 17874255
[TBL] [Abstract][Full Text] [Related]
9. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome.
Black JE; Hirshkowitz M
Sleep; 2005 Apr; 28(4):464-71. PubMed ID: 16171291
[TBL] [Abstract][Full Text] [Related]
10. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
Högl B; Saletu M; Brandauer E; Glatzl S; Frauscher B; Seppi K; Ulmer H; Wenning G; Poewe W
Sleep; 2002 Dec; 25(8):905-9. PubMed ID: 12489899
[TBL] [Abstract][Full Text] [Related]
11. Why choose modafinil for excessive daytime sleepiness?
Tobin ML
Issues Ment Health Nurs; 2007 Mar; 28(3):313-7. PubMed ID: 17454283
[No Abstract] [Full Text] [Related]
12. Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial.
Chapman JL; Kempler L; Chang CL; Williams SC; Sivam S; Wong KK; Yee BJ; Grunstein RR; Marshall NS
Thorax; 2014 Mar; 69(3):274-9. PubMed ID: 24287166
[TBL] [Abstract][Full Text] [Related]
13. Modafinil : a review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder.
Keating GM; Raffin MJ
CNS Drugs; 2005; 19(9):785-803. PubMed ID: 16142993
[TBL] [Abstract][Full Text] [Related]
14. Modafinil for excessive sleepiness associated with shift-work sleep disorder.
Czeisler CA; Walsh JK; Roth T; Hughes RJ; Wright KP; Kingsbury L; Arora S; Schwartz JR; Niebler GE; Dinges DF;
N Engl J Med; 2005 Aug; 353(5):476-86. PubMed ID: 16079371
[TBL] [Abstract][Full Text] [Related]
15. Armodafinil, the R-enantiomer of modafinil: wake-promoting effects and pharmacokinetic profile in the rat.
Wisor JP; Dement WC; Aimone L; Williams M; Bozyczko-Coyne D
Pharmacol Biochem Behav; 2006 Nov; 85(3):492-9. PubMed ID: 17134745
[TBL] [Abstract][Full Text] [Related]
16. Armodafinil and modafinil in patients with excessive sleepiness associated with shift work disorder: a pharmacokinetic/pharmacodynamic model for predicting and comparing their concentration-effect relationships.
Darwish M; Bond M; Ezzet F
J Clin Pharmacol; 2012 Sep; 52(9):1328-42. PubMed ID: 22039290
[TBL] [Abstract][Full Text] [Related]
17. Armodafinil for excessive daytime sleepiness.
Nishino S; Okuro M
Drugs Today (Barc); 2008 Jun; 44(6):395-414. PubMed ID: 18596995
[TBL] [Abstract][Full Text] [Related]
18. Modafinil use in patients with a primary psychiatric illness.
Black W; Hoey P; Mayze T
Aust N Z J Psychiatry; 2010 Jun; 44(6):583-4. PubMed ID: 20482418
[No Abstract] [Full Text] [Related]
19. Pharmacokinetic profile of armodafinil in healthy subjects: pooled analysis of data from three randomized studies.
Darwish M; Kirby M; Hellriegel ET; Yang R; Robertson P
Clin Drug Investig; 2009; 29(2):87-100. PubMed ID: 19133704
[TBL] [Abstract][Full Text] [Related]
20. Effect of Wakefulness-Promoting Agents on Sleepiness in Patients with Sleep Apnea Treated with CPAP: A Meta-Analysis.
Sukhal S; Khalid M; Tulaimat A
J Clin Sleep Med; 2015 Oct; 11(10):1179-86. PubMed ID: 25979103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
